Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-22T05:58:15.788Z Has data issue: false hasContentIssue false
  • English
  • Français

Management of a Sabiá Virus-Infected Patient in a US Hospital

Published online by Cambridge University Press:  02 January 2015

Lori R. Armstrong ,
Louise-Marie Dembry ,
Petrie M. Rainey ,
Mark B. Russi ,
Ali S. Khan ,
Steven H. Fischer ,
Stephen C. Edberg ,
Thomas G. Ksiazek ,
Pierre E. Rollin  and
C.J. Peters
Lori R. Armstrong
Affiliation:
Viral Exanthems and Herpesvirus Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia
Louise-Marie Dembry
Affiliation:
Department of Epidemiology and Infection Control, Yale University School of Medicine, Occupational Health Services, Yale-New Haven Hospital, New Haven, Connecticut
Petrie M. Rainey
Affiliation:
Department of Laboratory Medicine, Yale University School of Medicine, Occupational Health Services, Yale-New Haven Hospital, New Haven, Connecticut
Mark B. Russi
Affiliation:
Occupational and Environmental Medicine Program, Yale University School of Medicine, Occupational Health Services, Yale-New Haven Hospital, New Haven, Connecticut
Ali S. Khan
Affiliation:
Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia
Steven H. Fischer
Affiliation:
Clinical Pathology Department, National Institutes of Health, Bethesda, Maryland
Stephen C. Edberg
Affiliation:
Department of Laboratory Medicine, Yale University School of Medicine, Occupational Health Services, Yale-New Haven Hospital, New Haven, Connecticut
Thomas G. Ksiazek
Affiliation:
Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia
Pierre E. Rollin*
Affiliation:
Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia
C.J. Peters
Affiliation:
Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Special Pathogens Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop G-14, Atlanta, GA 30333
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To describe the hospital precautions used to isolate a Sabiá virus (arenavirus: Arenaviridae)-infected patient in a US hospital and to protect hospital staff and visitors.

Design:

Investigation of a single case of arenavirus laboratory-acquired infection and associated case-contacts.

Setting:

A 900-bed, tertiary-care, university-affiliated medical center.

Patients or other Participants:

The case-patient became ill with Sabiá virus infection. The case-contacts consisted of healthcare workers, coworkers, friends, and relatives of the case-patient.

Intervention:

Enhanced isolation precautions for treatment of a viral hemorrhagic fever (VHF) patient were implemented in the clinical laboratory and patient-care setting to prevent nosocomial transmission. The enhanced precautions included preventing aerosol spread of the virus from the patient or his clinical specimens. All case-contacts were tested for Sabiá virus antibodies and monitored for signs and symptoms of early disease.

Results:

No cases of secondary infection occurred among 142 case-contacts.

Conclusions:

With the frequency of worldwide travel, patients with VHF can be admitted to a local hospital at any time in the United States. The use of enhanced isolation precautions for VHF appeared to be effective in preventing secondary cases by limiting the number of contacts and promoting proper handling of laboratory specimens. Patients with VHF can be managed safely in a local hospital setting, provided that appropriate precautions are planned and implemented.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 20 , Issue 3 , March 1999 , pp. 176 - 182
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Peters, CJ, Jahrling, PB, Khan, AS. Patients infected with high-hazard viruses: scientific basis for infection control. Arch Virol 1996;11(suppl):141–168.Google Scholar
2. Carey, DE, Kemp, GE, White, HA, Pinneo, L, Addy, RF, Fom, AL, et al. Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg 1972;66:402–407.Google Scholar
3. Smith, EA, A review of Lassa fever outbreaks in Nigeria. Nigerian Medical Journal 1974;4:216–219.Google Scholar
4. Fraser, DW, Campbell, CC, Monadi, TP, Goff, PA, Gregg, MB. Lassa fever in the eastern province of Sierra Leone, 1970-1972, I: epidemiologic studies. Am J Trop Med Hyg 1974;23:1131–1139.Google Scholar
5. Fisher-Hoch, SP, Tomori, O, Nasidi, A, Perez-Oronoz, GI, Fakile, Y, Hutwagner, L, et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 1995;311:857–859.Google Scholar
6. Coimbra, LTM, Nassar, ES, Burattini, MN. New arenavirus isolated in Brazil. Lancet 1994;343:391–392.Google Scholar
7. Vasconcelos, PFC, Travassos da Rosa, APA, Rodrigues, SG, Tesh, R, Travassos da Rosa, JFS, Travassos da Rosa, ES. Infecção humana adquirida em laboratório causada pelo virus SPH 114202 (Arenavirus: familia Arenaviridae): aspectos clínicos e laboratoriais. Rev Inst Med Trop Sao Paulo 1993;35:521–525.CrossRefGoogle Scholar
8. Centers for Disease Control and Prevention. Arenavirus infection— Connecticut, 1994. MMWR 1994;43:635–636.Google Scholar
9. Barry, M, Russi, M, Armstrong, L, Geller, D, Tesh, R, Dembry, L, et al. Brief report: treatment of a laboratory acquired Sabiá virus infection. N Engl J Med 1995;333:294–296.Google Scholar
10. Centers for Disease Control and Prevention. Management of patients with suspected viral hemorrhagic fever. MMWR 1988;37(suppl S-3):1–16.Google Scholar
11. Centers for Disease Control and Prevention. Update: management of patients with suspected viral hemorrhagic fever—United States. MMWR 1995;44:475–479.Google Scholar
12. Centers for Disease Control and Prevention. Report of the External Advisory Committee. Review of Biosafety Issues Surrounding the Sabiá Virus Laboratory Infection, Yale Arbovirus Research Unit, Yale University. [C.J. Peters, Committee Chair.] Atlanta, GA CDC; 1994.Google Scholar
13. Centers for Disease Control and Prevention and National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories. 3rd ed. Atlanta, GA US Department of Health and Human Services, Public Health Service; 1993. DHHS publication no. (CDC) 93-8395.Google Scholar
14. Sato, H, Miyata, H, Watanabe, Y. Physiochemical inactivation of zoonotic viruses: hemorrhagic fever with renal syndrome and lymphocytic choriomeningitis viruses. Scandinavian Journal of Laboratory Animal Science 1988;15:113–125.Google Scholar
15. Holmes, GP, McCormick, JB, Trock, SC, Chase, RA, Lewis, SM, Mason, CA, et al. Lassa fever in the United States. N Engl J Med 1990;323:1120–1123.Google Scholar
16. Gandsman, EJ, Aaslestad, HG, Ouimet, TC, Rupp, WD. Sabiá virus incident at Yale University. Am Ind Hyg Assoc J 1997;58:51–53.Google Scholar
17. Bolyard, EA, Tablan, OC, Williams, WW, Pearson, ML, Shapiro, CN, Deitchman, SD, et al. Guidelines for Infection Control in Healthcare Personnel, 1998. Infect Control Hosp Epidemiol 1998;19:407–463.CrossRefGoogle ScholarPubMed
18. Garner, JS, and the Hospital Infection Control Practices Advisory Committee. Guidelines for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53–80.CrossRefGoogle ScholarPubMed
19. Monath, TP, Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ 1975;52:577–592.Google Scholar
20. Peters, CJ, Kuehne, RW, Mercado, RR, Le Bow, RH, Spertzel, RO, Webb, PA. Hemorrhagic fever in Cochabamba, Bolivia, 1971. Am J Epidemiol 1974;99:425–433.Google Scholar
21. Kilgore, PE, Peters, CJ, Mills, JN, Rollin, PE, Armstrong, L, Khan, AS, et al. Prospects for the control of Bolivian hemorrhagic fever. Emerg Infect Dis 1995;1:97–100.Google Scholar